Obseva SA OBSV:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
2.76quote price arrow down-0.04 (-1.43%)
Volume
7,256
Close
2.80quote price arrow up+0.03 (+1.08%)
Volume
474,779
52 week range
1.85 - 6.30

...

Loading . . .
  • Open2.87
  • Day High2.93
  • Day Low2.79
  • Prev Close2.77
  • 52 Week High6.30
  • 52 Week High Date07/02/20
  • 52 Week Low1.85
  • 52 Week Low Date11/03/20

Key Stats

  • Market Cap161.14M
  • Shares Out57.55M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change34.62

KEY STATS

  • Open2.87
  • Day High2.93
  • Day Low2.79
  • Prev Close2.77
  • 52 Week High6.30
  • 52 Week High Date07/02/20
  • 52 Week Low1.85
  • 52 Week Low Date11/03/20
  • Market Cap161.14M
  • Shares Out57.55M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change34.62

RATIOS/PROFITABILITY

  • EPS (TTM)-1.49
  • P/E (TTM)-1.88
  • Fwd P/E (NTM)-2.68
  • EBITDA (MRQ)-77.969M
  • ROE (MRQ)-185.20%
  • Revenue (MRQ)20,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-426,878.90%
  • Debt To Equity (MRQ)54.21%

EVENTS

  • Earnings Date08/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Obseva SA

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban...
Frank Verwiel M.D.
Non-Executive Chairman
Brian O'Callaghan
Chief Executive Officer
David Renas CPA., J.D.
Chief Financial Officer
Address
Chemin des Aulx 12
Plan-les-ouates
1228
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
ONCS
OncoSec Medical Inc
4.02-0.07-1.71%
CTIC
CTI Biopharma Corp
2.25+0.03+1.35%
MTNB
Matinas BioPharma Holdings Inc
0.7906-0.0134-1.6667%
MIST
Milestone Pharmaceuticals Inc
5.73+0.17+3.06%
ENLV
Enlivex Therapeutics Ltd
10.04+0.13+1.31%